The report provides a detailed analysis essential for establishing a Piperacillin Tazobactam production plant. It encompasses all critical aspects necessary for Piperacillin Tazobactam production, including the cost of Piperacillin Tazobactam production, Piperacillin Tazobactam plant cost, Piperacillin Tazobactam production costs, and the overall Piperacillin Tazobactam production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Piperacillin Tazobactam production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Piperacillin Tazobactam is a potent combined formulation of the antibacterial properties of the antibiotic piperacillin with those of the beta-lactamase inhibitor tazobactam. Tazobactam suppresses the production of the enzyme beta-lactamase, which the bacteria manufacture to withstand antibiotic therapy, while piperacillin targets both gram-positive and gram-negative bacteria. Thus, this combined formulation of these two antibiotics provides a potent therapeutic alternative for complicated infections, including pneumonia, skin infections, and intra-abdominal infections. Additionally, it is widely utilized in the form of injection for the treatment of various infections caused by bacteria, including skin infection, pneumonia, gynecological, and stomach infections.
The market for piperacillin-tazobactam is driven by the increasing occurrence of bacteria that are resistant to antibiotics, indicating the need for more sophisticated treatment alternatives. Moreover, its utilization as a medication for the treatment of a wide range of infections, including stomach infections, pneumonia, urinary tract infections, and other serious infections, further promotes its demand in the medical and pharmaceutical industries. Furthermore, several factors influence industrial Piperacillin Tazobactam procurement, such as the availability of raw materials (DCM (dichloromethane), etc.), cost and pricing, compliance with pharmaceutical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Piperacillin Tazobactam Production
According to the Piperacillin Tazobactam production plant project report, the major raw materials for Piperacillin Tazobactam production include Ampicillin-DCM (dichloromethane) solution - 4-Ethyl-2,3-dioxo-1-piperazinecarbonyl chloride (EDPC).
Production Process of Piperacillin Tazobactam
The extensive Piperacillin Tazobactam production cost report consists of the following industrial production process:
- Production via Ampicillin (AMP) Chloride method: This method of production involves N-acylation of DCM (dichloromethane) solution of 4-ethyl-2,3-dioxo-1-piperazinecarbonyl chloride (EDPC) at the oil-water interface by using an aqueous solution of Ampicillin (AMP) in a membrane dispersion microreactor, which results in the formation of Piperacillin. Additionally, the other drug, tazobactam, which is a penicillanic acid sulphone, is obtained from 6-aminopenicllanic acid. Further, these two drugs are combined in the determined ratio to obtain a Piperacillin-Tazobactam as a combination drug.
Piperacillin Tazobactam is a form of mixed preparation of two antibiotics, piperacillin and tazobactam. The compound’s molecular formula is C33H38N9NaO12S2, and its molar mass is 839.8 g/mol. Moreover, this combination drug finds its application as a potent antibiotic with an expanded spectrum of antibacterial activity. This combined formulation is often marketed by certain other names, which include Tazocin (TN), Zosyn (TN), and Piperacillin-tazobactam mixt.